1	"	"	``	_	4	punct	_
2	Shareholders	shareholder	NNS	_	4	nsubj	4:A1=PPT
3	should	should	MD	_	4	aux	4:AM-MOD
4	be	be	VB	pb=be.01	13	ccomp	13:A1=PPT
5	careful	careful	JJ	_	4	acomp	4:A2=PRD
6	about	about	IN	_	5	prep	_
7	Pfizer	pfizer	NNP	_	9	poss	_
8	's	's	POS	_	7	possessive	_
9	bid	bid	NN	_	6	pobj	_
10	,	,	,	_	13	punct	_
11	"	"	''	p2=``	13	punct	_
12	Borg	borg	NNP	_	13	nsubj	13:A0=PAG
13	told	tell	VBD	pb=tell.01	0	root	_
14	reporters	reporter	NNS	_	13	dobj	13:A2=GOL
15	.	.	.	_	13	punct	_

1	"	"	``	_	3	punct	_
2	There	there	EX	_	3	expl	_
3	is	be	VBZ	pb=be.02	0	root	_
4	a	a	DT	_	6	det	_
5	significant	significant	JJ	_	6	amod	_
6	development	development	NN	_	3	attr	3:A1=PPT
7	of	of	IN	_	6	prep	_
8	new	new	JJ	_	9	amod	_
9	drugs	drug	NNS	_	7	pobj	_
10	in	in	IN	_	6	prep	_
11	AstraZeneca	astrazeneca	NNP	_	10	pobj	_
12	.	.	.	_	3	punct	_

1	If	if	IN	_	6	mark	_
2	they	they	PRP	_	6	nsubj	6:A0=PAG;8:A0=PAG;13:A0=PAG
3	(	(	-LRB-	p2=VBP	2	punct	_
4	Pfizer	pfizer	NNP	_	2	appos	_
5	)	)	-RRB-	_	2	punct	_
6	start	start	VBP	p2=VB|pb=start.01	23	advcl	23:AM-ADV
7	to	to	TO	_	8	aux	_
8	divide	divide	VB	pb=divide.02	6	xcomp	6:A1=PPT
9	up	up	RP	_	8	prt	8:C-V
10	the	the	DT	_	11	det	_
11	company	company	NN	_	8	dobj	8:A1=PPT
12	and	and	CC	_	8	cc	_
13	put	put	VBD	p2=VB|pb=put.01	8	conj	_
14	it	it	PRP	_	13	dobj	13:A1=PPT
15	together	together	RB	_	13	advmod	13:A2=GOL
16	with	with	IN	_	13	prep	13:AM-MNR
17	different	different	JJ	_	18	amod	_
18	parts	part	NNS	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	Pfizer	pfizer	NNP	p2=NN	19	pobj	_
21	,	,	,	_	23	punct	_
22	there	there	EX	_	23	expl	_
23	is	be	VBZ	pb=be.02	0	root	_
24	a	a	DT	_	25	det	_
25	danger	danger	NN	_	23	attr	23:A1=PPT
26	that	that	IN	p2=WDT	30	complm	_
27	the	the	DT	_	28	det	_
28	process	process	NN	_	30	nsubj	30:A1=PPT
29	will	will	MD	_	30	aux	30:AM-MOD
30	be	be	VB	pb=be.01	25	ccomp	_
31	complicated	complicated	JJ	p2=VBN	30	acomp	30:A2=PRD
32	.	.	.	_	23	punct	_
33	"	"	''	_	23	punct	_

1	Borg	borg	NNP	_	3	nsubj	3:A0
2	also	also	RB	_	3	advmod	3:AM-DIS
3	said	say	VBD	pb=say.01	0	root	_
4	Pfizer	pfizer	NNP	_	6	poss	_
5	's	's	POS	_	4	possessive	_
6	shareholders	shareholder	NNS	_	8	nsubj	8:A0=PAG
7	should	should	MD	_	8	aux	8:AM-MOD
8	ask	ask	VB	pb=ask.01	3	ccomp	3:A1=PPT
9	themselves	themselves	PRP	_	8	dobj	8:A2=GOL
10	whether	whether	IN	_	13	complm	_
11	they	they	PRP	_	13	nsubj	13:A0
12	should	should	MD	_	13	aux	13:AM-MOD
13	support	support	VB	pb=support.01	8	ccomp	8:A1=PPT
14	the	the	DT	_	15	det	_
15	company	company	NN	_	17	poss	_
16	's	's	POS	_	15	possessive	_
17	management	management	NN	_	13	dobj	13:A1
18	in	in	IN	_	13	prep	13:AM-MNR
19	its	its	PRP$	_	21	poss	_
20	aggressive	aggressive	JJ	_	21	amod	_
21	pursuit	pursuit	NN	_	18	pobj	_
22	of	of	IN	_	21	prep	_
23	AstraZeneca	astrazeneca	NNP	_	22	pobj	_
24	.	.	.	_	3	punct	_

1	This	this	DT	_	2	det	_
2	discussion	discussion	NN	_	5	nsubjpass	5:A1=PPT
3	is	be	VBZ	_	5	auxpass	_
4	now	now	RB	_	5	advmod	5:AM-TMP
5	closed	close	VBN	p2=JJ|pb=close.01	0	root	_
6	.	.	.	_	5	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	welcome	welcome	VBP	pb=welcome.01	0	root	_
3	comments	comment	NNS	_	2	dobj	2:A1=PPT
4	on	on	IN	_	3	prep	_
5	our	our	PRP$	_	6	poss	_
6	articles	article	NNS	_	4	pobj	_
7	for	for	IN	_	6	prep	_
8	a	a	DT	_	10	det	_
9	limited	limited	JJ	_	10	amod	_
10	period	period	NN	_	7	pobj	_
11	after	after	IN	_	10	prep	_
12	their	their	PRP$	_	13	poss	_
13	publication	publication	NN	_	11	pobj	_
14	.	.	.	_	2	punct	_

